vaccine available News
-
Company doctor vaccinates at HSM
Since 07.06.2021, vaccination prioritisation in Germany has been lifted and anyone interested can apply for an appointment to be vaccinated against Covid 19, regardless of age or previous illnesses. But it is not as easy as it sounds – appointments in vaccination centres are rarely available and there is also great demand among general practitioners. For this reason, HSM GmbH + Co. KG ...
-
The GRAM paper gives face to the AMR crisis - Vaxdyn’s comment about the GRAM paper
The experts of the Anti-Microbial Resistance (AMR) world, including Vaxdyn’s researchers, have been warning about the entrance into a post-antibiotic era or the occurrence of a silent pandemic for years. However, the general public, including health practitioners, did not understand the message or underscored the magnitude of the problem. Recently, a vast network of AMR experts around the ...
-
Lumen Bioscience Partners with Leading Animal Health Company to Develop Oral Biologic Drugs and Reduce Antibiotic Use on Farms
Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced a research collaboration with a top-three animal health company to develop orally delivered biologic drugs to reduce the use of antibiotics in animal husbandry. The collaboration’s initial focus is on development of therapeutic proteins against ...
-
Amyris Completes First Major License For Leading RNA Vaccine Advancing Technology To Human Trials
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it has signed an exclusive license with Nant Africa, LLC relating to the development and use of the RNA COVID vaccine Amyris developed in coordination with the Infectious ...
-
FAO, OIE and WHO unite for World Rabies Day to call for elimination of disease
The Food and Agriculture Organization of the United Nations (FAO), the World Organisation for Animal Health (OIE) and the World Health Organization (WHO) have issued the following joint statement on the occasion of World Rabies Day. United Against Rabies On World Rabies Day – 28 September – FAO, OIE and WHO unite in their goal to eliminate human rabies and control the disease in ...
-
Vaccine protects from deadly Hendra virus
Dr Deborah Middleton from CSIRO’s Australian Animal Health Laboratory (AAHL) will announce the successful progress to develop the vaccine at the Australian Veterinary Association conference in Adelaide today. “Our trials so far have shown that the vaccine prevents the infection of horses with Hendra virus,” Dr Middleton said. Stopping the disease in horses could also help ...
-
Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its participation in a newly expanded investigator-initiated Phase 2 clinical trial called Comparing COVID-19 Vaccine Schedule Combinations – Stage 2 (Com-COV2), to be conducted by the University of Oxford and supported by the UK Vaccines Taskforce. ...
By Novavax
-
Visit of His Majesty the King of the Belgians Philippe and Her Majesty the Queen of the Belgians Mathilde to Afrigen Biologics
HM King Philippe and HM Queen Mathilde, currently on a state visit to South Africa until March 27, visited the Afrigen Biologics facility in Cape Town to learn more about how two Belgian companies, Univercells and etherna, are supporting the development of the first African- developed mRNA COVID-19 vaccine. The King and The Queen are accompanied by five ministers of federal and regional ...
By eTheRNA
-
Over-the-counter COVID-19 testing now available at CVS Pharmacy
CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), today announced the availability of three over-the-counter COVID-19 testing options in stores and online. The tests include the Ellume COVID-19 Home Test, the Abbott BinaxNOW COVID-19 Antigen Self Test and the Pixel by Labcorp PCR Test Home Collection Kit. All three tests have received FDA Emergency Use Authorization (EUA), do not ...
-
Breakthrough in the global battle against polio: AJ Vaccines granted WHO prequalification for new polio vaccine
International vaccine manufacturer, AJ Vaccines has received WHO prequalification for Picovax®, the first stand-alone dose sparing Inactivated Polio Vaccine (IPV) on 21st April 2020. First deliveries to UN agencies such as UNICEF and PAHO are expected by mid-2020. COPENHAGEN, 22 April 2020 – Despite ongoing concerted efforts to eradicate polio, it appears to be on the rise again with ...
-
INOVIO Announces First Subject Dosed in Phase 1B Clinical Trial for its DNA Vaccine Against Lassa Fever, INO-4500, in West Africa
INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced the first participant was dosed in a Phase 1B clinical trial for INO-4500, its DNA vaccine candidate for Lassa fever, in Ghana. The Phase 1B clinical trial (LSV-002), ongoing at the Noguchi Memorial Institute ...
-
Access to quick, reliable, and repeated testing has been one of the greatest challenges for businesses, institutions and individuals during the COVID-19 crisis.
HOK teamed with Germfree Laboratories Inc. to design a mobile testing lab that will help large organizations meet this urgent need. These self-contained, biocontainment facilities can provide advanced, on-site capabilities for any setting,. Leveraging Germfree’s experience manufacturing mobile biosafety labs and HOK’s expertise in lab planning, the BSL 2+ level labs offer a rapidly ...
-
CVS Caremark to offer US$5 million in free flu shots to uninsured patients of community clinics and health centers beginning September 20
CVS Caremark announced today that it will partner with Direct Relief USA to offer up to US$5 million in free flu shots to community clinic and health center patients who lack health insurance. Direct Relief USA is a non-profit organization that works with 1,100 clinics and health centers in all 50 states, providing them with free medications and supplies for their low-income and uninsured ...
-
Dyadic and bYoRNA Announce a Collaboration Targeting the Production of Abundant, Low-Cost mRNA From C1-Cells
Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI) and bYoRNA SAS (“bYoRNA”) today announced that they entered into a development and commercialization agreement to work on disruptive bioproduction technologies that will help exploit the therapeutic potential of messenger RNA (“mRNA”). Dyadic is a global biotechnology company focused on building innovative ...
-
Vaxdyn introduces its multi-pathogen vaccine candidate KapaVax at the World Vaccine Congress Europe
In an oral presentation within the track “AMR & Bacterial Vaccines”, chaired by Dr Jan Poolman (Bacterial Vaccine Discovery and Early Development, Janssen), Dr. Infante showed how Vaxdyn’s technology can deliver endotoxin-free inactivated whole cell vaccines presenting outer-membrane proteins of different bacteria in the surface, therefore raising immunity against ...
-
DOD to Fund a Multi-Center Randomized Clinical Trial of COVID-19 Treatment with ExThera’s Seraph 100 Blood Filter
After encouraging preliminary results in the treatment of critically-ill COVID-19 patients at a military hospital in the United States and fourteen other hospitals in Europe, the Department of Defense has selected the Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) as one of its main interventions in a pivotal, US-based randomized controlled trial. Financial support for the ...
-
Virometix Announces Publication of Key Non-Clinical Proof-ofConcept Data in Two High Quality Peer-Reviewed Journals
Virometix, a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious diseases and cancer conditions, today announces publication of key non-clinical proof-of-concept data on its lead vaccine candidate V-306 in two high quality peer-reviewed journals. The data confirm the potential of V-306 for ...
By Virometix AG
-
FDA Authorizes New High-Throughput, Automated System for Leading COVID-19 Test
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the Thermo Fisher Scientific Amplitude Solution with the TaqPath COVID-19 High-Throughput Combo Kit. Amplitude Solution with TaqPath COVID-19 High-Throughput Combo Kit enables labs to scale ...
-
Vaxcyte Doses First Participants in Phase 1/2 Clinical Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
Company Expects to Announce Topline Results from the Phase 1/2 Study by the End of 2022 Proof-of-Concept Study Will Evaluate the Safety, Tolerability and Immunogenicity of VAX-24 VAX-24 is a 24-Valent Pneumococcal Conjugate Vaccine Designed to Deliver Broad-Spectrum Protection Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to ...
-
Vaxcyte Doses First Participants in Phase 2 Portion of Ongoing VAX-24 Phase 1/2 Clinical Proof-of-Concept Study in Adults
Following Prespecified Review of Phase 1 Safety and Tolerability Data, Independent Data Monitoring Committee Recommends Study Proceed as Planned Company Expects to Announce Topline Results from Both the Phase 1 and Phase 2 Portions of the Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease and Pneumonia by the End of 2022 VAX-24 is a 24-Valent Pneumococcal Conjugate ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you